T 0239/16 (Zoledronic acid/NOVARTIS) of 13.09.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T023916.20170913
- Date of decision
- 13 September 2017
- Case number
- T 0239/16
- Petition for review of
- -
- Application number
- 05012711.7
- IPC class
- A61P 19/10A61K 31/663A61P 19/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method of administering bisphosphonates
- Applicant name
- Novartis AG
Novartis Pharma GmbH - Opponent name
- Generics [UK] Limited
Sanovel Ilaç Sanayi ve Ticaret A.S.
Taylor Wessing LLP - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(1)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Public availability of document (yes)
Main and auxiliary request: novelty - (yes)
Main and auxiliary request: inventive step - (no) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.